MOSPD2 is a therapeutic target for the treatment of CNS inflammationClinical & Experimental ImmunologyApril 30, 202010.1111/cei.13448Cited by 14SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis